✦ LIBER ✦

PSY12 ECONOMIC AND CLINICAL EFFICACY BENEFITS OF THE USE OF USTEKINUMAB IN THE TREATMENT OF MODERATE TO SEVERE PSORIASIS IN GREECE

✍ Scribed by L Xaplanteris; S Papanicolaou

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PSS8 COST EFFICACY OF USTEKINUMAB IN TRE

✍ M Tatar; F Sarioz 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

Budget impact analysis of ustekinumab in

✍ Georgia Avgerinou, Ioannis Bassukas, Georgios Chaidemenos, Andreas Katsampas, Ma 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 205 KB

PSY30 Cost-Effectiveness of Ustekinumab

✍ Valencia-Mendoza, A.; Hernández-Garduño, A.; Puig, A. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PSY8 Budget Impact Analysis of Ustekinum

✍ Tangwongsiri, D.; Leartsakulpanitch, J. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

PSS12 MODELING THE COST-EFFECTIVENESS OF

✍ S Verma; S Dharmarajan; Y Yang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PSY46 PATTERNS OF CARE IN THE PHARMACOLO

✍ CS Hankin; M Lebwohl; J Knispel; JD Dunn; M Lopes; A Bronstone; Z Wang 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB